3 Firms Guide $568M Biopharma Go-Public Deal
Blank-check company Tottenham Acquisition said Wednesday it's merging with Clene Nanomedicine, a clinical-stage neurodegenerative disease-focused biopharmaceutical company, in a $568 million deal guided by three law firms....To view the full article, register now.
Already a subscriber? Click here to view full article